Cargando…
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
BACKGROUND: The necessity to measure and reward “value for money” of new pharmaceuticals has become central in health policy debates, as much as the requirement to assess the “willingness to pay” for an additional, quality-adjusted life year (QALY). There is a clear need to understand the capacity o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243324/ https://www.ncbi.nlm.nih.gov/pubmed/32440753 http://dx.doi.org/10.1186/s13561-020-00267-y |